FGF23 and delirium: A technical validation of the differentially expressed FGF-23 protein via enzyme-linked immunosorbent assays further reinforced the generalizability of our results, suggesting that circulating FGF-23 may serve as a serum biomarker of delirium post-cardiac surgery.